Alterations of cellular organelles in human liver-derived hepatoma G2 cells induced by adriamycin

Anti-Cancer Drugs

Volumn 20, Issue 9, 2009, Pages 779-786

  Qian, Haoran ^a   Yang, Yi ^b  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

Adriamycin (doxorubicin); Autophagy; Hepatoma G2 cells; Mitochondria

Indexed keywords

DOXORUBICIN;

ARTICLE; CANCER CELL CULTURE; CELL DEATH; CELL ORGANELLE; CELL STRUCTURE; CELL VACUOLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; GOLGI COMPLEX; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MITOCHONDRION; PRIORITY JOURNAL;

ANTIBIOTICS, ANTINEOPLASTIC; AUTOPHAGY; CARCINOMA, HEPATOCELLULAR; CELL DEATH; CELL LINE, TUMOR; DOXORUBICIN; HEPATOCYTES; HUMANS; MICROSCOPY, ELECTRON, TRANSMISSION; ORGANELLES;

EID: 70349152646     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/CAD.0b013e32832f4e6f     Document Type: Article

References (19)

1. Olweny CL, Toya T, Katongole-Mbidde E, Mugerwa J, Kyalwazi SK, Cohen H. Treatment of hepatocellular carcinoma with adriamycin. Cancer 1975; 36:1250-1257.
2. Otten SL, Stutzman-Engwall KJ, Hutchinson CR. Cloning and expression of daunorubicin biosynthesis genes from Streptomyces peucetius and S. peucetius subsp. caesius. J Bacteriol 1990; 172:3427-3434.
3. Gewirtz DA. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem Pharmacol 1999; 57:727-741.
4. Chang G, Roth CB. Structure of MsbA from E. coli: a homolog of the multidrug resistance ATP binding cassette (ABC) transporters. Science 2001; 293:1793-1800.
5. Lasagna N, Fantappie O, Solazzo M, Morbidelli L, Marchetti S, Cipriani G, et al. Hepatocyte growth factor and inducible nitric oxide synthase are involved in multidrug resistance-induced angiogenesis in hepatocellular carcinoma cell lines. Cancer Res 2006; 66:2673-2682.
6. Barraud L, Merle P, Soma E, Lefrancois L, Guerret S, Chevallier M, et al. Increase of doxorubicin sensitivity by doxorubicin-loading into nanoparticles for hepatocellular carcinoma cells in vitro and in vivo. J Hepatol 2005; 42:736-743.
7. Ye N, Qin J, Liu X, Shi W, Lin B. Characterizing doxorubicin-induced apoptosis in HepG2 cells using an integrated microfluidic device. Electrophoresis 2007; 28:1146-1153.
8. Kim SJ, Park KM, Kim N, Yeom YI. Doxorubicin prevents endoplasmic reticulum stress-induced apoptosis. Biochem Biophys Res Commun 2006; 339:463-468.
9. Arancia G, Calcabrini A, Meschini S, Molinari A. Intracellular distribution of anthracyclines in drug resistant cells. Cytotechnology 1998; 27:95-111.
10. Yang Y, Fukui K, Koike T, Zheng XX. Induction of autophagy in neurite degeneration of mouse superior cervical ganglion neurons. Eur J Neurosci 2007; 26:2979-2988.
11. Fukuda M. Lysosomal membrane glycoproteins. Structure, biosynthesis, and intracellular trafficking. J Biol Chem 1991; 266:21327-21330.
12. Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T, Noda T, et al. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J 2000; 19:5720-5728.
13. Lee TK, Lau TC, Ng IO. Doxorubicin-induced apoptosis and chemosensitivity in hepatoma cell lines. Cancer Chemother Pharmacol 2002; 49:78-86.
14. Viktorsson K, Lewensohn R, Zhivotovsky B. Apoptotic pathways and therapy resistance in human malignancies. Adv Cancer Res 2005; 94:143-196.
15. Kim R, Emi M, Tanabe K. The role of apoptosis in cancer cell survival and therapeutic overcome. Cancer Biol Ther 2006; 5:1429-1442.
16. Park SS, Kim MA, Eom YW, Choi KS. Bcl-xL blocks high dose doxorubicin-induced apoptosis but not low dose doxorubicin-induced cell death through mitotic catastrophe. Biochem Biophys Res Commun 2007; 363:1044-1049.
17. Reggiori F, Klionsky DJ. Autophagy in the eukaryotic cell. Eukaryot Cell 2002; 1:11-21.
18. Codogno P, Meijer AJ. Autophagy and signaling: their role in cell survival and cell death. Cell Death Differ 2005; 12:1509-1518.
19. Kondo Y, Kanzawa T, Sawaya R, Kondo S. The role of autophagy in cancer development and response to therapy. Nat Rev Cancer 2005; 5:726-734.